Artelo Biosciences annual net debt
2020
2021
2021
2022
2023
2024
2025
Artelo Biosciences Net Debt Growth & History (ARTL)
Artelo Biosciences's net debt was −$94,000 for fiscal 2025.
View full Artelo Biosciences company overviewArtelo Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$94,000 | $2.1M | — |
| 2024 | 2024-12-31 | −$2.2M | $581,000 | — |
| 2023 | 2023-12-31 | −$2.8M | $4.0M | — |
| 2022 | 2022-12-31 | −$6.9M | $5.2M | — |
| 2021 · Dec 31 | 2021-12-31 | −$12.1M | — | — |
| 2021 · Aug 31 | 2021-08-31 | −$6.6M | −$4.4M | — |
| 2020 | 2020-08-31 | −$2.1M | — | — |
Artelo Biosciences quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$4.1M | −$2.2M | — |
| Q1 2026 | 2026-03-31 | −$3.7M | −$3.0M | — |
| Q4 2025 | 2025-12-31 | −$94,000 | $2.1M | — |
| Q3 2025 | 2025-09-30 | −$766,000 | $3.5M | — |
| Q2 2025 | 2025-06-30 | −$2.0M | −$1.2M | — |
| Q1 2025 | 2025-03-31 | −$651,000 | $448,000 | — |
| Q4 2024 | 2024-12-31 | −$2.2M | $581,000 | — |
| Q3 2024 | 2024-09-30 | −$4.2M | −$1.6M | — |
| Q2 2024 | 2024-06-30 | −$794,000 | $4.9M | — |
| Q1 2024 | 2024-03-31 | −$1.1M | $5.8M | — |
| Q4 2023 | 2023-12-31 | −$2.8M | $4.0M | — |
| Q3 2023 | 2023-09-30 | −$2.6M | $4.4M | — |
| Q2 2023 | 2023-06-30 | −$5.7M | $6.4M | — |
| Q1 2023 | 2023-03-31 | −$6.9M | $3.4M | — |
| Q4 2022 | 2022-12-31 | −$6.9M | $5.2M | — |
| Q3 2022 | 2022-09-30 | −$7.1M | — | — |
| Q2 2022 | 2022-06-30 | −$12.1M | — | — |
| Q1 2022 · Mar 31 | 2022-03-31 | −$10.3M | — | — |
| Q4 2021 · Dec 31 | 2021-12-31 | −$12.1M | — | — |
| Q1 2022 · Nov 30 | 2021-11-30 | −$14.0M | −$6.6M | — |
| Q4 2021 · Aug 31 | 2021-08-31 | −$6.6M | −$4.4M | — |
| Q3 2021 | 2021-05-31 | −$10.1M | — | — |
| Q2 2021 | 2021-02-28 | −$10.7M | — | — |
| Q1 2021 | 2020-11-30 | −$7.4M | — | — |
| Q4 2020 | 2020-08-31 | −$2.1M | — | — |
Artelo Biosciences net debt trends
Between the periods ended 2020-08-31 and 2025-12-31, Artelo Biosciences's net debt increased from −$2.1M to −$94,000, a change of $2.0M. The latest reported quarter, Q2 2026, shows −$4.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artelo Biosciences source filings ↗